TECCRO Showcases Pioneering Research on Alopecia Treatments at ISCR 2025

From January 30th to February 1st, 2025, TECCRO proudly participated in the prestigious Indian Society for Clinical Research (ISCR) event, presenting three groundbreaking studies that showcased its advancements in cutting-edge research. The presentations included a prospective pilot study on the efficacy of a patented biomimetic polypeptide hair growth factor formulation for treating persistent chemotherapy-induced alopecia, an evaluation of the synergistic effect of low-level light therapy (LLLT) combined with the patented biomimetic formulation for androgenetic alopecia, and a comparative study highlighting the superior efficacy of the patented biomimetic polypeptide formulation over growth factor concentrate (GFC) treatments. These studies reflect TECCRO’s commitment to pioneering innovative solutions and transforming patient care. The event provided an invaluable platform to engage with the scientific community, reinforcing TECCRO’s role as a leader in clinical research and its dedication to bridging the gap between research and real-world applications.

Adding to this accolades received by Ms. Riya Shahare’s poster presentation, “Synergistic Effect of Low-Level Light Therapy (LLLT) Combined with a Patented Biomimetic Formulation for Androgenetic Alopecia,” received a consolation prize, marking a proud achievement for TECCRO. This recognition underscores our unwavering dedication to high-quality research, innovation, and evidence-based advancements.